Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.71 |
| ▸ | PPARG | P37231 | 7/20 | 0.71 |
| ▸ | PPARD | Q03181 | 7/20 | 0.71 |
| ▸ | PPARA | Q07869 | 7/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.71 |
| ▸ | TSHR | P16473 | 4/20 | 0.71 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.71 |
| ▸ | FABP4 | P15090 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | TLR2 | O60603 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.71 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.71 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.71 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myristic Acid SCHEMBL28567039 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL9107897 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Nonanoate SCHEMBL30561579 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Nonanoate SCHEMBL30561576 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Behenic Acid SCHEMBL1857976 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Dodecanoate SCHEMBL23781813 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL29377017 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL31743253 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL10596204 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Nonanoate SCHEMBL30561573 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103421605-B | Method and its application that oils and fatss are carried with erythritol fatty acid ester point | 丰益(上海)生物技术研发中心有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-103421605-A | Method for fractionating grease through using erythritol fatty acid ester, and application of erythritol fatty acid ester | FENGYI SHANGHAI BIOTECHNOLOGY RES & DEV CT CO LTD | 2013-12-04 | — | — | CN | disclosed |
| US-20120142744-A1 | NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES | ASTION DERMATOLOGY A/S | 2012-06-07 | — | — | US | disclosed |
| US-8084049-B2 | Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives | ASTION DERMATOLOGY A/S (DK) | 2011-12-27 | — | — | US | disclosed |
| EP-1560589-B1 | NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND NIACINAMIDE | ASTION DERMATOLOGY AS (DK) | 2006-10-04 | — | — | EP | disclosed |
| US-20060069131-A1 | Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives | ASTION DERMATOLOGY A/S | 2006-03-30 | — | — | US | disclosed |
| EP-1640011-A1 | Novel complexes of fatty acid esters of polyhydroxylalkanes and pyridine carboxy derivates | Astion Dermatology A/S (DK) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142744-A1 | NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES | FFAR3, FADS1, FASN | GPR84 167/4885PPARG 21/4885PPARD 62/4885 |
| US-20060069131-A1 | Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives | FFAR3, FADS1, FASN | GPR84 168/4885PPARG 18/4885PPARD 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.